Vaccines could be a key means of suppressing bird flu and avoiding the slaughter of millions of chickens, which is blamed for ...

A mysterious disease has hit poultry farms in Telangana's Wanaparthy district, leading to the sudden deaths of around 2,500 chickens in three days. Veterinary officials are investigating the cause ...

Good morning, everyone. I'm Robert Coates, Global Head of Investor Relations for Marex. Thank you for joining us today for our results conference call. Speaking today are Ian Lowitt, CEO ...

Revenue grew by 28% to $415.6m (Q4 2023: $325.6m) with strong organic growth across all businesses driven by robust client activity, market share gains and supportive market conditions. We ...

Health and Human Services Secretary Robert F. Kennedy Jr. warned vaccines could turn "birds into mutant factories." ...

Barclays analyst Benjamin Budish raised the firm’s price target on Marex Group (MRX) to $43 from $39 and keeps an Overweight rating on the shares following the Q4 report. The company reported an ...

Barclays analyst Benjamin Budish maintained a Buy rating on Marex Group plc (MRX – Research Report) today and set a price target of $39.00. The company’s shares closed last Friday at $36.64.

Good day, and thank you for standing by. Welcome to the Marex Q4 and Full Year 2024 Conference Call and Webcast. At this time all participants are in listen-only mode. After the speakers ...

These are non-IFRS financial measures. See Appendix 1 “Non-IFRS Financial Measures and Key Performance Indicators” for additional information and for a reconciliation of each such IFRS measure ...

Marex Group plc has announced it will release its 2024 fourth quarter and full year results on March 6, 2025, before market opening. The earnings announcement and accompanying materials will be ...